Search
Galecto Ord Shs
DMRAAdd to Watchlist
26.430USD
-0.170-0.64%
Close 04/20, 16:00（ET）Quotes delayed by 15 min
42.22MMarket Cap
LossP/E TTM
More Details of Company
Galecto Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Galecto Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Interim Principal Executive Officer, Chief Operating Officer
Interim Principal Executive Officer, Chief Operating Officer
190.38K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
+94.14%
Mr. Garrett Winslow
Mr. Garrett Winslow
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
1.85K
+22.92%
Ms. Lori Firmani
Ms. Lori Firmani
Interim Chief Financial Officer
Interim Chief Financial Officer
931.00
+25.67%
Dr. Jayson D.A. Dallas, M.D.
Dr. Jayson D.A. Dallas, M.D.
Independent Director
Independent Director
--
--
Dr. Carl M. Goldfischer, M.D.
Dr. Carl M. Goldfischer, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Amit D. Munshi
Mr. Amit D. Munshi
Independent Director
Independent Director
--
-100.00%
Mr. Matthew (Matt) Kronmiller
Mr. Matthew (Matt) Kronmiller
Executive Vice President of Strategy, Chief Business Officer
Executive Vice President of Strategy, Chief Business Officer
--
--
Mr. Peter Harwin
Mr. Peter Harwin
Independent Director
Independent Director
--
--
Dr. Chris W. Cain, Ph.D.
Dr. Chris W. Cain, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Sherwin Sattarzadeh
Mr. Sherwin Sattarzadeh
Interim Principal Executive Officer, Chief Operating Officer
Interim Principal Executive Officer, Chief Operating Officer
190.38K
--
Ms. Julianne Bruno
Ms. Julianne Bruno
Independent Director
Independent Director
137.03K
+94.14%
Mr. Garrett Winslow
Mr. Garrett Winslow
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
1.85K
+22.92%
Ms. Lori Firmani
Ms. Lori Firmani
Interim Chief Financial Officer
Interim Chief Financial Officer
931.00
+25.67%
Dr. Jayson D.A. Dallas, M.D.
Dr. Jayson D.A. Dallas, M.D.
Independent Director
Independent Director
--
--
Dr. Carl M. Goldfischer, M.D.
Dr. Carl M. Goldfischer, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Apr 13
Updated: Mon, Apr 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
VR Adviser, LLC
5.98%
Ikarian Capital LLC
0.56%
Hewes (Lemuel Becker)
0.44%
Fidelity Management & Research Company LLC
0.40%
Sattarzadeh (Sherwin)
0.32%
Other
92.32%
Shareholders
Shareholders
Proportion
VR Adviser, LLC
5.98%
Ikarian Capital LLC
0.56%
Hewes (Lemuel Becker)
0.44%
Fidelity Management & Research Company LLC
0.40%
Sattarzadeh (Sherwin)
0.32%
Other
92.32%
Shareholder Types
Shareholders
Proportion
Venture Capital
6.02%
Individual Investor
1.06%
Hedge Fund
0.94%
Investment Advisor
0.68%
Corporation
0.40%
Investment Advisor/Hedge Fund
0.34%
Research Firm
0.13%
Other
90.42%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
52
4.80M
7.95%
+3.88M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
VR Adviser, LLC
3.60M
5.98%
+3.60M
--
Feb 09, 2026
Ikarian Capital LLC
335.71K
0.56%
+50.00K
+17.50%
Feb 28, 2026
Hewes (Lemuel Becker)
264.63K
0.44%
+264.63K
--
Jan 05, 2026
Fidelity Management & Research Company LLC
238.88K
0.4%
--
--
Dec 31, 2025
Sattarzadeh (Sherwin)
190.38K
0.32%
+190.38K
--
Jan 05, 2026
Bruno (Julianne)
137.03K
0.23%
+129.00K
+1606.08%
Feb 09, 2026
Jain Global LLC
120.57K
0.2%
+120.57K
--
Dec 31, 2025
Remedium Capital Partners, LLC
120.47K
0.2%
+120.47K
--
Dec 31, 2025
Paramora Holding LLC
120.47K
0.2%
+120.47K
--
Nov 10, 2025
Paragon Therapeutics Inc
120.47K
0.2%
+120.47K
--
Nov 10, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
